ID22897A - Turunan isoksazol - Google Patents

Turunan isoksazol

Info

Publication number
ID22897A
ID22897A IDW991245A ID991245A ID22897A ID 22897 A ID22897 A ID 22897A ID W991245 A IDW991245 A ID W991245A ID 991245 A ID991245 A ID 991245A ID 22897 A ID22897 A ID 22897A
Authority
ID
Indonesia
Prior art keywords
group
formula
represented
solid line
single bond
Prior art date
Application number
IDW991245A
Other languages
English (en)
Indonesian (id)
Inventor
Masashi Nakatsuka
Yoshihide Ueno
Shin-Ichiro Okada
Fumio Nishikaku
Original Assignee
Sumitomo Pharmaceutical Compan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceutical Compan filed Critical Sumitomo Pharmaceutical Compan
Publication of ID22897A publication Critical patent/ID22897A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
IDW991245A 1997-04-21 1998-04-17 Turunan isoksazol ID22897A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11887197 1997-04-21
JP36715497 1997-12-24

Publications (1)

Publication Number Publication Date
ID22897A true ID22897A (id) 1999-12-16

Family

ID=26456721

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991245A ID22897A (id) 1997-04-21 1998-04-17 Turunan isoksazol

Country Status (14)

Country Link
EP (1) EP0979226B1 (zh)
KR (1) KR100512087B1 (zh)
CN (1) CN1138764C (zh)
AT (1) ATE309228T1 (zh)
AU (1) AU733091B2 (zh)
CA (1) CA2235298C (zh)
DE (1) DE69832270T2 (zh)
DK (1) DK0979226T3 (zh)
ES (1) ES2248894T3 (zh)
ID (1) ID22897A (zh)
NZ (1) NZ330244A (zh)
RU (1) RU2196770C2 (zh)
TW (1) TW442476B (zh)
WO (1) WO1998047880A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2377527A1 (en) * 1999-07-15 2001-01-25 Sumitomo Pharmaceuticals Co., Ltd. Heteroaromatic ring compounds
WO2001047895A1 (fr) * 1999-12-28 2001-07-05 Sumitomo Pharmaceuticals Company, Limited Nouveaux composes comprenant des cycles heteroaromatiques a cinq chainons
ES2292721T3 (es) 2001-03-27 2008-03-16 Dainippon Sumitomo Pharma Co., Ltd. Derivado de isoxazol cristalino y preparacion medica del mismo.
JPWO2003068239A1 (ja) * 2002-02-12 2005-06-02 住友製薬株式会社 新規外用剤
ITMI20040019A1 (it) * 2004-01-12 2004-04-12 Univ Bari Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
DE102004008141A1 (de) * 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
CA2589808A1 (en) * 2004-11-02 2006-05-11 Dainippon Sumitomo Pharma Co., Ltd. Combination drug for treating autoimmune disease
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase
JP5969505B2 (ja) * 2011-01-28 2016-08-17 ４エスツェー ディスカバリー ゲゼルシャフト ミット ベシュレンクテル ハフツング 自己免疫性炎症の治療のためのＩＬ１７及びＩＦＮ−γ阻害
DE102014201651A1 (de) 2014-01-30 2015-07-30 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Isoxazolderivate zur Verwendung bei der Behandlung und/oder Prophylaxe von Herzerkrankungen
CN111269149B (zh) * 2020-04-08 2022-04-15 南京优氟医药科技有限公司 一种5-(3,3-二甲基胍基)-2-氧代戊酸的生产工艺
CN114478350B (zh) * 2022-01-25 2023-08-11 苏州大学 一种c3-烷基化吲哚的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068418A1 (en) * 1969-10-27 1971-08-27 Innothera Lab Sa 2-substd-5-amino isoxazole derivs
US3720685A (en) * 1970-07-15 1973-03-13 Squibb & Sons Inc 3-amino-5-benzyl-1,2,4-oxadiazoles
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
DE2341507A1 (de) * 1973-08-16 1975-02-27 Thomae Gmbh Dr K Neue biphenylderivate und verfahren zur herstellung
JPS54144347A (en) * 1978-05-02 1979-11-10 Nikken Kagaku Kk 3-(2-fluoro-4-biphenylyl)-2-butanone
HU180567B (en) * 1980-03-19 1983-03-28 Egyt Gyogyszervegyeszeti Gyar Method for producing derivatives of isooxazole
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
US4680300A (en) * 1985-01-10 1987-07-14 Syntex (U.S.A.) Inc. Anti-inflammatory guanidines
US4914112A (en) * 1986-06-03 1990-04-03 Sumitomo Pharmaceuticals Company, Limited Aminoazole derivatives and their production and use
JP2719742B2 (ja) * 1991-04-30 1998-02-25 株式会社大塚製薬工場 フェニルチアゾール誘導体

Also Published As

Publication number Publication date
AU6193498A (en) 1998-10-22
NZ330244A (en) 2000-01-28
CN1252794A (zh) 2000-05-10
DE69832270D1 (de) 2005-12-15
DE69832270T2 (de) 2006-07-13
CA2235298C (en) 2008-05-13
ES2248894T3 (es) 2006-03-16
DK0979226T3 (da) 2006-03-06
EP0979226A1 (en) 2000-02-16
ATE309228T1 (de) 2005-11-15
EP0979226B1 (en) 2005-11-09
CA2235298A1 (en) 1998-10-21
CN1138764C (zh) 2004-02-18
WO1998047880A1 (en) 1998-10-29
RU2196770C2 (ru) 2003-01-20
AU733091B2 (en) 2001-05-03
KR100512087B1 (ko) 2005-09-05
TW442476B (en) 2001-06-23
KR20010006501A (ko) 2001-01-26

Similar Documents

Publication Publication Date Title
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
ID22897A (id) Turunan isoksazol
CA2030718A1 (en) Tricyclic Compounds
CA2318349A1 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
EP1302458A4 (en) ESTERDERIVATE
EP1026149A4 (en) AMIDOCARBONSÄUREDERIVATE
DE69418243D1 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
GB9815163D0 (en) Compounds
ATE466861T1 (de) Aminderivate
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
DK1004573T3 (da) Aryloxyanilinderivater
ATE289810T1 (de) Ecteinascidinderivate
IE873155L (en) A benzo-furan(or -thiophene) derivative and processes for preparing the same.
EA199800155A1 (ru) Новое соединение
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
EP0335979A4 (en) Thienopyrimidine derivatives
KR920004392A (ko) 플루오로에틸캄프토테신 유도체
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
ATE238300T1 (de) (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine
AU1424795A (en) Indole derivative
EP0302633A3 (en) Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
DK0386778T3 (da) Biphenylderivater
DK378087D0 (da) Tetracycliske indolderivater
CA2245896A1 (en) A therapeutic agent for renal disease